Consumer Driven Elective Procedures Stocks
Specialized medical technology and service providers in this sector capitalize on high-margin, out-of-pocket patient spending for aesthetic enhancements, vision correction, and elective orthopedic interventions.
As of Oct 23, 2026, Consumer Driven Elective Procedures has 11 US-listed companies worth $16.2B combined. The median member moved -1.3% over the past week; ESTA led at +7.8% and APYX trailed at -7.1%.
Companies in Consumer Driven Elective Procedures
- ALGN – Align Technology Inc, $11B
- ESTA – Establishment Labs Holdings Inc, $1.8B
- STAA – STAAR Surgical Company, $1.1B
- INMD – InMode Ltd, $811M
- SBC – SBC Medical Group Holdings Incorporated, $538M
- EOLS – Evolus Inc, $472M
- SY – So-Young International Inc, $273M
- APYX – Apyx Medical Inc, $107M
- AIRS – Airsculpt Technologies Inc, $91.9M
- PAIYY – Aesthetic Medical International Holdings Group Limited, $535,563
- VIVE – Viveve Medical Inc, $2,144